Life Technologies is a global biotechnology tools company providing premier systems, consumables, and services for scientific researchers around the world.
Life Technologies customers conduct their research across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st-century forensics.
With more than 50,000 products used by more than 75,000 customers around the globe, Life Technologies is advancing scientific research in areas like academic research, drug discovery and development, toxicology and forensics, disease diagnostics, clinical cell therapy and regenerative medicine, and biologics manufacturing.
Life Technologies is a strong proponent of global corporate social responsibility. Through the Life Technologies Foundation, our company has donated millions of dollars to help demystify the world of science, empower today’s children to become tomorrow’s scientific leaders, and deepen society’s appreciation of science.
The company is also proud of its global citizenship and efforts to reduce its environmental impact; we have reduced our CO2 emissions by 36% since 2006 and energy consumption by 32% since 2004. Life Technologies is a member of FTSE4Good Index Series and the Dow Jones Sustainability Index, where it was Biotechnology Sector Leader in 2008.
Life Technologies' brands are found in more than 90% of research laboratories in the United States.
Life Technologies is the leading supplier of stem cell research consumables and products.
Life Technologies spends approximately $300 million per year in research and development.
Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology tools company dedicated to improving the human condition.
Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics.
Life Technologies had sales of more than $3.3 billion in 2009, employs approximately 9,000 people, has a presence in 160 countries, and possesses a rapidly growing intellectual property estate of approximately 3,900 patents and exclusive licenses.
Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc in November of 2008.